The nuclear lamina and inherited disease

Trends in Cell Biology

Volumn 12, Issue 12, 2002, Pages 591-598

  Worman, Howard J ^a   Courvalin, Jean Claude ^b  

^a Columbia University ^*  (United States)

^b INSTITUT JACQUES MONOD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIN A; LAMIN C;

ACCURACY; ADIPOSE TISSUE; CELL STRUCTURE; CYTOLOGY; GENE MUTATION; HUMAN; LIPODYSTROPHY; MEDICAL RESEARCH; MUSCLE DISEASE; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE; SOMATIC CELL; TISSUE SPECIFICITY; ANIMAL; CHEMISTRY; DISEASE MODEL; GENETIC DISORDER; GENETICS; METABOLISM; MUTATION; NUCLEAR LAMINA; PATHOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; GENETIC DISEASES, INBORN; HUMANS; LAMIN TYPE A; MUTATION; NUCLEAR LAMINA;

EID: 0036899615     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(02)02401-7     Document Type: Review

References (54)

1. Stuurman N., et al. Nuclear lamins: their structure, assembly, and interactions. J. Struct. Biol. 122:1998;42-66.
2. McKeon F.D., et al. Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature. 319:1986;463-468.
3. Fisher D.Z., et al. cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins. Proc. Natl. Acad. Sci. U. S. A. 83:1986;6450-6454.
4. Weber K., et al. Maturation of nuclear lamin A involves a specific carboxy-terminal trimming, which removes the polyisoprenylation site from the precursor; implications for the structure of the nuclear lamina. FEBS Lett. 257:1989;411-414.
5. Sinensky M., et al. The processing pathway of prelamin A. J. Cell Sci. 107:1994;61-67.
6. Worman H.J., Courvalin J-C. The inner nuclear membrane. J. Membr. Biol. 177:2000;1-11.
7. Bione S., et al. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat. Genet. 8:1994;323-327.
8. Emery A.E.H., Dreifuss F.E. Unusual type of benign X-linked muscular dystrophy. J. Neurol. Neurosurg. Psychiatry. 29:1966;338-342.
9. Nagano A., et al. Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy. Nat. Genet. 12:1996;254-259.
10. Manilal S., et al. The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. Hum. Mol. Genet. 5:1996;801-808.
11. Bonne G., et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet. 21:1999;285-288.
12. Raffaele di Barletta M., et al. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am. J. Hum. Genet. 66:2000;1407-1412.
13. Fatkin D., et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N. Engl. J. Med. 341:1999;1715-1724.
14. Muchir A., et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum. Mol. Genet. 9:2000;1453-1459.
15. Bonne G., et al. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann. Neurol. 48:2000;170-180.
16. Peters J.M., et al. Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nat. Genet. 18:1998;292-295.
17. Cao H., Hegele R.A. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9:2000;109-112.
18. Shackleton S., et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat. Genet. 24:2000;153-156.
19. Speckman R.A., et al. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am. J. Hum. Genet. 66:2000;1192-1198.
20. Vigouroux C., et al. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes. 49:2000;1958-1962.
21. Novelli G., et al. Mandibuloacral dysplasia Is caused by a mutation in LMNA-encoding lamin A/C. Am. J. Hum. Genet. 71:2002;426-431.
22. De Sandre-Giovannoli A., et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am. J. Hum. Genet. 70:2002;726-736.
23. Garg A., et al. Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene. Am. J. Med. 112:2002;549-555.
24. Sullivan T., et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell Biol. 147:1999;913-920.
25. Vigouroux C., et al. Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene. J. Cell Sci. 114:2001;4459-4468.
26. Pendás A.M., et al. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat. Genet. 31:2002;94-99.
27. Kilic F., et al. In vitro assay and characterization of the farnesylation-dependent prelamin A endoprotease. J. Biol. Chem. 272:1997;5298-5304.
28. Sewry C.A., et al. Skeletal muscle pathology in autosomal dominant Emery-Dreifuss muscular dystrophy with lamin A/C mutations. Neuropathol. Appl. Neurobiol. 27:2001;281-290.
29. Östlund C., et al. Intracellular trafficking of emerin, the Emery-Dreifuss muscular dystrophy protein. J. Cell Sci. 112:1999;1709-1719.
30. Ellenberg J., et al. Nuclear membrane dynamics and reassembly in living cells: targeting of an inner nuclear membrane protein in interphase and mitosis. J. Cell Biol. 138:1997;1193-1206.
31. Wu W., et al. Intracellular trafficking of MAN1, an integral protein of the nuclear envelope inner membrane. J. Cell Sci. 115:2002;1361-1371.
32. Fairley E.A., et al. The Emery-Dreifuss muscular dystrophy phenotype arises from aberrant targeting and binding of emerin at the inner nuclear membrane. J. Cell Sci. 112:1999;2571-2582.
33. Clements L., et al. Direct interaction between emerin and lamin A. Biochem. Biophys. Res. Commun. 267:2000;709-714.
34. Sakaki M., et al. Interaction between emerin and nuclear lamins. J. Biochem. 129:2001;321-327.
35. Harborth J., et al. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114:2001;4557-4565.
36. Gruenbaum Y., et al. The expression, lamin-dependent localization and RNAi depletion phenotype for emerin in C. elegans. J. Cell Sci. 115:2002;923-929.
37. Vaughan A., et al. Both emerin and lamin C depend on lamin A for localization at the nuclear envelope. J. Cell Sci. 114:2001;2577-2590.
38. Östlund C., et al. Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy. J. Cell Sci. 114:2001;4435-4445.
39. Raharjo W.H., et al. Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy. J. Cell Sci. 114:2001;4447-4457.
40. Cohen M., et al. Transcriptional repression, apoptosis, human disease and the functional evolution of the nuclear lamina. Trends Biochem. Sci. 26:2001;41-47.
41. Hutchison C.J., et al. Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes? J. Cell Sci. 114:2001;9-19.
42. Wilson K.L., et al. Lamins and disease: insights into nuclear infrastructure. Cell. 104:2001;647-650.
43. Cremer T., Cremer C. Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat. Rev. Genet. 2:2001;292-301.
44. Chubb J.R., et al. Chromatin motion is constrained by association with nuclear compartments in human cells. Curr. Biol. 12:2002;439-445.
45. Daigle N., et al. Nuclear pore complexes form immobile networks and have a very low turnover in live mammalian cells. J. Cell Biol. 154:2001;71-84.
46. Spann T.P., et al. Alteration of nuclear lamin organization inhibits RNA polymerase II-dependent transcription. J. Cell Biol. 156:2002;603-608.
47. Tsukahara T., et al. CDNA microarray analysis of gene expression in fibroblasts of patients with x-linked Emery-Dreifuss muscular dystrophy. Muscle Nerve. 25:2002;898-901.
48. Maniotis A.J., et al. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc. Natl. Acad. Sci. U. S. A. 94:1997;849-854.
49. Chien K.R. Stress pathways and heart failure. Cell. 98:1999;555-558.
50. Cutler D.A., et al. Characterization of adiposity and metabolism in Lmna-deficient mice. Biochem. Biophys. Res. Commun. 291:2002;522-527.
51. Holt I., et al. The R482Q lamin A/C mutation that causes lipodystrophy does not prevent nuclear targeting of lamin A in adipocytes or its interaction with emerin. Eur. J. Hum. Genet. 9:2001;204-208.
52. Dhe-Paganon S., et al. Structure of the globular tail of nuclear lamin. J. Biol. Chem. 277:2002;17381-17384.
53. Krimm I., et al. The Ig-like structure of the C-terminal domain of lamin a/c, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. Structure. 10:2002;811-823.
54. Hoffmann K., et al. Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huët anomaly). Nat. Genet. 31:2002;410-414.